Global WholeHealth Partners Corp. approved tests and including Dengue, Ebola, Zika, TB and Malaria for international sales, also offers one of the largest lines of tests for CoViD19 SARS2, and is prepared to help in the fight against CoViD19 SARS2. With the pandemic still not under control in the United States, and new variants coming out, Global needed to make sure it kept up with the needs of the nation and the world. With the new “More Highly Contagious COVID-19 Strain” quickly spreading throughout the US and the rest of the world, Global WholeHealth Partners Corp. confirms their Antibody and Antigen Test Kits detect the mutated COVID-19 strain, like the newest variant DELTA (B1.6117.2), the UK strain (B.1.1.7) and the South Africa (B.1.351). The Delta variant was first identified in India in December 2020 and led to major outbreaks in the country. It then spread rapidly and is now reported in 104 countries, according to a CDC tracker. As of early July, Delta has become the dominant form of the coronavirus in the U.S., U.K., Germany, and other countries. In the U.K., for instance, the Delta variant now makes up more than 97% of new COVID-19 cases, according to Public Health England.